Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension-Reference-Cited by-同舟云学术

Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension

Published:2018-10-24 Issue:4 Volume:115 Page:776-787
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Krishnan Shalini M¹,Ling Yeong H¹,Huuskes Brooke M²,Ferens Dorota M¹,Saini Narbada²,Chan Christopher T¹,Diep Henry¹²,Kett Michelle M³,Samuel Chrishan S¹,Kemp-Harper Barbara K¹,Robertson Avril A B⁴,Cooper Matthew A⁴,Peter Karlheinz⁵,Latz Eicke⁶⁷⁸,Mansell Ashley S⁹,Sobey Christopher G¹²,Drummond Grant R¹²,Vinh Antony¹²

Affiliation:

1. Department of Pharmacology, Monash University, Clayton, Victoria, Australia

2. Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia

3. Department of Physiology, Monash University, Clayton, Victoria, Australia

4. Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia

5. Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

6. Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany

7. Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA

8. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

9. Hudson Institute of Medical Research, Clayton, Victoria, Australia

Funder

National Health and Medical Research Council of Australia